Author: Shwu

23andMe Meet and Greet Tuesday December 20th

Calling all Bay Area locals! Would you like to get a personal introduction to personal genetics? Meet some of the people behind the company and the product? Stock up on the most unique gift you can give? Now is your chance. Come to Bumble in Los Altos on Tuesday, December 20th to learn more about 23andMe, ...

Read more

23andMe and Montreal: Reflections From ICHG 2011

Congratulations to Diana Cousminer, the winner of our Exome Giveaway!* Hailing from Finland, Diana is extremely excited to be one of the first people to have her exome sequenced. "I felt like a huge geek because no one at home understood what I had won or why I was so fired up until I explained what an ...

Read more

Milestones in the Fight Against Parkinson’s Disease

It's been an exciting year for research on Parkinson's disease. In March, scientists from Stanford were able to recreate features of the disease in a petri dish using cells from a Parkinson's patient. In June, we published a paper in PLoS Genetics detailing our discovery of two novel genetic associations with ...

Read more

“50/50″ Shows Us the Human Side of Cancer

With Kim Barnholt From the minute it became clear that Adam had cancer, he became a statistic, a diagnosis, a “case study”. One of the statistics he made sure to read up on were his chances of surviving. The odds -- 50/50 -- didn’t seem fair in the context of his life, but his friend Kyle put it into a ...

Read more

SNPWatch: Genetic Variation Influences How We Respond to Reinforcement

By Bethann Hromatka   Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will ...

Read more

FDA to Hold Public Town Hall Discussion in San Francisco

In March earlier this year, 23andMe presented its views on possible federal regulation of the direct-to-consumer (DTC) genetic testing industry at an Advisory Committee meeting convened by the FDA. We reiterated our belief that individuals have a right to access their own genetic information without physician ...

Read more

23andMe’s Third Publication Demonstrates Efficient Replication of Over 180 Genetic Associations

As we’ve mentioned here previously, science can be a slow process. Researchers spend a long time -- sometimes upward of five years -- gathering enough people with a particular disease to study, collecting samples and data from them, analyzing that data, and then publishing the results. Imagine if you had to ...

Read more

Controversial Longevity Paper Formally Retracted

Last summer, a study published in the journal Science on the genetics of human longevity made a splash when the authors claimed that they had identified a genetic signature that could predict with 77% accuracy whether someone would live past 100. The bold findings immediately came under fire from other ...

Read more

SNPwatch: Genetic Variants Linked to Progressive Supranuclear Palsy

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

A Recipe for Disease Research: Give People Tools, Add Passion, and Shake

[Update: View a video recap of Sarcoma Community Night at http://www.23andme.com/sarcoma/] Three. That was the average number of patients enrolled in studies for sarcoma four years ago when Nathalie Criou, a sarcoma cancer survivor and founder of Beat Sarcoma, looked around for new information about her ...

Read more

Return to top